Summary
The pharmacokinetics of ampicillin and propylthiouracil were studied in 6 and 9 patients, respectively, before and several times up to a year after a shunt operation for extreme obesity. The drugs were given intravenously and orally making it possible to estimate the absolute bioavailability. The bioavailability of propylthiouracil (about 80%) was unchanged by the surgical procedure but the fraction of ampicillin (given as pivampicillin) absorbed decreased from a preoperative value of 109 ± 44% to 44 ± 30% 12 months after the bypass operation. Volumes of distribution transiently decreased in the postoperative period for ampicillin. Clearance was initially reduced for both ampicillin and propylthiouracil after operation but returned to normal values a year later. Half-lives of both drugs were unchanged.
These results are compared with previous data on pharmacokinetics in intestinal shunt patients and a tabular review is presented. Although no general rules presently emerge from the data available, it seems prudent to closely monitor intestinal shunt patients on drug therapy by both laboratory and clinical methods.
Similar content being viewed by others
References
Andreasen, P.B.; Danö, P.; Kirk, H. and Greisen, G.: Drug absorption and hepatic drug metabolism in patients with different typres of intestinal shunt operation for obesity. A study with Phenazone. Scandinavian Journal of Gastroenterology 12: 531–535 (1977).
Azizi, E.; Belur, R. and Albano, J.: Malabsorption of thyroid hormones after jejunoileal bypass for obesity. Annals of Internal Medicine 90: 941–942 (1979).
Backman, L.; Beerman, B.; Groschinsky-Grind, M. and Hallberg, D.: Malabsorption of hydrochlorothiazide following intestinal shunt surgery. Clinical Pharmacokinetics 4: 63–68 (1979).
Barry, R.E.; Barisch, J.; Bray, G.A.; Sperling, M.A.; Morin, R.J. and Benfield, J.: Intestinal adaptation after jejunoileal bypass in man. American Journal of Clinical Nutrition 30: 32–42 (1977).
Battershill, J.H.: Tuberculosis after intestinal bypass surgery for obesity. Chest 70: 318 (1976).
Beermann, B.; Hellström, K. and Rosen, A.: The gastrointestinal absorption of digoxin in seven patients with gastric or small intestinal reconstructions. Acta Medica Scandinavica 193: 293–297 (1973).
Bray, G.A.: Current status of intestinal bypass surgery in the treatment of obesity. Diabetes 26: 1072–1079 (1977).
Bruce, R.M. and Wise, L.: Tuberculosis after jejunoileal bypass for obesity. Annals of Internal Medicine 87: 574–576 (1977).
Danö, P.; Lenz, K. and Justesen, T.: Bile acid metabolism and intestinal bacterial flora after three types of intestinal shunt operation for obesity. Scandinavian Journal of Gastroenterology 9: 767–774 (1974).
DeWind, L.T. and Payne, J.H.: Intestinal bypass surgery for morbid obesity. Long-term results. Journal of the American Medical Association 236: 2298–2301 (1976).
Dudrick, S.J.; Daly, J.M.; Castro, G. and Akhtar, M.: Gastrointestinal adaptation following small bowel bypass for obesity. Annals of Surgery 185: 642–648 (1977).
Fenyö, G.; Backman, L. and Hallberg, D.: Morphological changes of the small intestine following jejunoileal shunt in obese subjects. Acta Chirurgica Scandinavica 142: 154–159 (1976).
Gerson, C.D.; Lowe, E.H. and Lindenbaum, J.: Bioavailability of digoxin tablets in patients with gastrointestinal dysfunction. American Journal of Medicine 69: 43–49 (1980).
Griffiths, T.M.; Thomas, P. and Campbell, I.A.: Antituberculosis drug levels after jejunoileal bypass. British Journal of Diseases of the Chest 76: 286–289 (1982).
Hallberg, D. and Backman, L.: Kinetics of the body weight after intestinal bypass operations in obesity. Acta Chirurgica Scandinavica 139: 557–562 (1973).
Heizer, W.D.; Smith, T.W. and Goldfinger, S.E.: Absorption of digoxin in patients with malabsorption syndromes. New England Journal of Medicine 285: 257–259 (1971).
Holzbach, R.T.: Hepatic effects of jejunoileal bypass for morbid obesity. American Journal of Clinical Nutrition 30: 43–52 (1977).
Hultberg, E.R. and Backelin, B.: Studies on the absorption of pivampicillin and ampicillin. Scandinavian Journal of Infectious Diseases 4: 149–153 (1972).
Iber, F.L. and Cooper, M.: Jejunoileal bypass for the treatment of massive obesity. Prevalence, morbidity, and short- and long-term consequences. American Journal of Clinical Nutrition 30: 4–15 (1977).
Johansson, E.D.B. and Krai, J.G.: Oral contraceptives after intestinal bypass operations. Journal of the American Medical Association 236: 2847 (1976).
Juhl, E.; Christoffersen, P.; Baden, H. and Quaade, F.: Liver morphology and biochemistry in eight obese patients treated with jejunoileal anastomosis. New England Journal of Medicine 285: 543–547 (1971).
Kampmann, J.; Lindahl, F.; Mølholm Hansen, J. and Siersbaek-Nielsen, K.: Effect of probenecid on the excretion of ampicillin in human bile. British Journal of Pharmacology 47: 782–786 (1973).
Kampmann, J. and Mølholm Hansen, J.: Clinical pharmacokinetics of antithyroid drugs. Clinical Pharmacokinetics 6: 401–428 (1981).
Kampmann, J. and Skovsted, L.: The pharmacokinetics of Propylthiouracil. Acta Pharmacologica et Toxicologica 35: 361–0369 (1974).
Kennedy, M.C. and Wade, D.N.: Phenytoin absorption in patients with ileojejunal bypass. British Journal of Clinical Pharmacology 7: 515–518 (1979).
Kern, W.H.; Heger, A.H.; Payne, J.H. and DeWind, L.T.: Fatty metamorphosis of the liver in morbid obesity. Archives of Pathology 96: 342–346 (1973).
Krausz, M.M.; Berry, E.; Freund, U. and Levy, M.: Absorption of orally administered digoxin after massive resection of the small bowel. American Journal of Gastroenterology 71: 220–223 (1979).
Loo, J.C.K.; Foltz, E.L.; Wallick, H. and Kwan, K.C.: Pharmacokinetics of pivampicillin and ampicillin in man. Clinical Pharmacology and Therapeutics 16: 35–43 (1974).
Manes, J.L.; Taylor, H.B. and Starkloff, G.B.: Relationship between hepatic morphology and clinical and biochemical findings in morbidly obese patients. Journal of Clinical Pathology 26: 776–783 (1973).
Marcus, F.I.; Quinn, E.J.; Horton, H.; Jacobs, S.; Pippin, S.; Stafford, M. and Zukoski, C: The effect of jejunoileal bypass on the pharmacokinetics of digoxin in man. Circulation 55: 537–541 (1977).
Payne, J.H. and DeWind, L.: Surgical treatment of obesity. American Journal of Surgery 118: 141–147 (1969).
Payne, J.H.; DeWind, L.T.; Schwab, D.E. and Kern, W.H.: Surgical treatment of morbid obesity. Archives of Surgery 106: 432–437 (1973).
Peterson, D.I. and Zweig, R.W.: Absorption of anticonvulsant after jejunoileal bypass. Bulletin of the Los Angeles Neurological Society 39: 51–55 (1974).
Pickleman, J.R.; Evans, L.S.; Kane, J.M. and Freeark, R.J.: Tuberculosis after jejunoileal bypass for obesity. Journal of the American Medical Association 234: 744 (1975).
Polk, R.E.; Tenenbaum, M. and Kline, B.: Isoniazid and ethambutol absorption with jejunoileal bypass. Annals of Internal Medicine 89: 430–431 (1978).
Quaade, F.; Juhl, E.; Feldt-Rasmussen, K. and Baden, H.: Blindloop reflux in relation to weight loss in obese patients treated with jejunoileal anastomosis. Scandinavian Journal of Gastroenterology 6: 537–541 (1971).
Scott, H.W.; Law, D.H.; Sandstead, H.H.; Lanier, V.C. and Younger, R.K.: Jejunoileal shunt in surgical treatment of morbid obesity. Annals of Surgery 171: 770–782 (1970).
Tuma, D.J.; Vanderhof, J.A. and Sorrell, M.F.: Impaired hepatic drug metabolism after jejunoileal bypass in rats. Journal of Pharmacology and Experimental Therapeutics 206: 167–171 (1978).
Wasson, K.R. and Harris, J.O.: The treatment of tuberculosis in the presence of malabsorpuon syndromes (MAS) [abstract]. American Review of Respiratory Diseases 113: 51 (1976).
Wills, C.E.: Tuberculosis after jejunoileal bypass. Journal of the American Medical Association 235: 1425 (1976).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kampmann, J.P., Klein, H., Lumholtz, B. et al. Ampicillin and Propylthiouracil Pharmacokinetics in Intestinal Bypass Patients Followed Up to a Year after Operation. Clin Pharmacokinet 9, 168–176 (1984). https://doi.org/10.2165/00003088-198409020-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003088-198409020-00004